| Title |
High doses of dextromethorphan, an NMDA antagonist, produce effects similar to classic hallucinogens
|
|---|---|
| Published in |
Psychopharmacology, April 2012
|
| DOI | 10.1007/s00213-012-2680-6 |
| Pubmed ID | |
| Authors |
Chad J. Reissig, Lawrence P. Carter, Matthew W. Johnson, Miriam Z. Mintzer, Margaret A. Klinedinst, Roland R. Griffiths |
| Abstract |
Although reports of dextromethorphan (DXM) abuse have increased recently, few studies have examined the effects of high doses of DXM. |
X Demographics
The data shown below were collected from the profiles of 15 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 4 | 27% |
| Denmark | 2 | 13% |
| Canada | 1 | 7% |
| Japan | 1 | 7% |
| Unknown | 7 | 47% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 11 | 73% |
| Scientists | 3 | 20% |
| Practitioners (doctors, other healthcare professionals) | 1 | 7% |
Mendeley readers
The data shown below were compiled from readership statistics for 139 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Chile | 1 | <1% |
| Netherlands | 1 | <1% |
| United States | 1 | <1% |
| South Africa | 1 | <1% |
| Unknown | 135 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 23 | 17% |
| Student > Bachelor | 17 | 12% |
| Researcher | 15 | 11% |
| Student > Ph. D. Student | 13 | 9% |
| Student > Doctoral Student | 10 | 7% |
| Other | 23 | 17% |
| Unknown | 38 | 27% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 30 | 22% |
| Psychology | 22 | 16% |
| Neuroscience | 15 | 11% |
| Pharmacology, Toxicology and Pharmaceutical Science | 9 | 6% |
| Agricultural and Biological Sciences | 7 | 5% |
| Other | 16 | 12% |
| Unknown | 40 | 29% |
Attention Score in Context
This research output has an Altmetric Attention Score of 14. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 May 2022.
All research outputs
#2,554,223
of 25,026,088 outputs
Outputs from Psychopharmacology
#611
of 5,590 outputs
Outputs of similar age
#15,083
of 166,255 outputs
Outputs of similar age from Psychopharmacology
#11
of 42 outputs
Altmetric has tracked 25,026,088 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,590 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.4. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 166,255 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 42 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 76% of its contemporaries.